Poor lifestyle choices, psychological stress, and other factors promote cortisol release and elevate ROS levels (Prasad et al., 2016)
Aran, D., Toperoff, G., Rosenberg, M
Due to this, the FDA recently announced their decision to halt the mass production of compounded GLP-1 drugs by May 22, an important step towards protecting patients from the potential risks associated with unapproved versions of these drugs
Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity
These agents have multiple effects relevant to brain health: improved glycemic control (lowering glucose spikes, avoiding hyperglycemia) weight loss, which reduces many risk factors (vascular disease, hypertension, dyslipidemia) possible reduction of systemic inflammation possible direct neural effects: crossingor affectingthe blood brain barrier
Months 3-6: Long-Term Collagen Remodeling The 3-6 month window is where GHK-Cu's deepest structural effects emerge